On the recordJanuary 10, 2022
One of the benefits of the oral antivirals Paxlovid and molnupiravir is that they have much broader activity against SARS-CoV-2 and its variants.
Source
congress.govOne of the benefits of the oral antivirals Paxlovid and molnupiravir is that they have much broader activity against SARS-CoV-2 and its variants.
Cassidy discusses the effectiveness of antiviral treatments against COVID-19 variants.
Share
More from Bill Cassidy
Yeah. Again, people always want to bring that up, and all I can say is you have to live life living forward.